METHOD FOR DETERMINING AND MANAGING TOTAL CARDIODIABETES RISK

摘要

A method for generating a report presenting a patient-specific information relevant to assessing a patient's cardiodiabetes risk to guide and allow a physician or healthcare provider in the choice of therapy or therapies that will be maximally effective for a specific patient, to monitor the response to the chosen therapy and reduce the patient's risk of developing cardiodiabetes and/or its complications.

主权项

1. In a computer processor, a method of generating a report presenting a patient-specific information relevant to assessing a patient's cardiodiabetes risk, the method comprising:
a. collecting, using the processor, the results of a biomarker test specific to a patient, wherein the biomarker test comprises quantitative measurement of at least one biomarker from at least three of the following panels: (1) a total glycemic control panel; (2) a beta cell function panel; (3) an insulin resistance panel; (4) an inflammation panel; and (5) a dyslipidemia panel; b. selecting, using the processor, a cardiodiabetes categorical risk level based on the patient's results of the biomarker test; c. organizing, using the processor, the results of the biomarker test and the cardiodiabetes categorical risk level in a patient-specific cardiodiabetes health report; and d. presenting the patient-specific cardiodiabetes health report, wherein the report comprises the cardiodiabetes categorical risk level assessing the cardiodiabetic health significance of the results of each biomarker test from each biomarker panel, wherein the cardiodiabetes categorical risk level is assigned based on a comparison of the biomarker test results of the patient with a reference value range.